Oct 15, 2026 / Payment Basics

Part B drugs payment systems

Research Areas:

Drugs, Devices, and Tests

Oct 15, 2026 / Payment Basics

Medicare Part B premium

Research Areas:

Drugs, Devices, and Tests

Sep 30, 2026 / Contractor Reports

Pharmacists’ Perspectives on Current Issues in Pharmacy and Medicare: Findings from 2026 Virtual Focus Groups

Research Areas:

Drugs, Devices, and Tests, Physicians And Other Health Professionals, Quality

Sep 09, 2026 / Comment Letters

MedPAC comment on CMS’s proposed rule on CY 2027 revisions to payment policies under the physician fee schedule and other changes to Part B payment policies

Research Areas:

Drugs, Devices, and Tests, Medicare Spending and Financing, Physicians And Other Health Professionals

Jul 16, 2026 / Data Book

July 2026 Data Book: Health Care Spending and the Medicare Program

Research Areas:

Ambulatory Care Settings, Beneficiaries and Coverage, Drugs, Devices, and Tests, Hospitals, Medicare Spending and Financing, Physicians And Other Health Professionals, Post-Acute Care, Private Plans, Quality

Jul 16, 2026 / Data Book

July 2026 Data Book Section 10: Prescription drugs

Research Areas:

Drugs, Devices, and Tests, Medicare Spending and Financing

Mar 04, 2026 / Transcripts

March 2026 public meeting transcript

Research Areas:

Beneficiaries and Coverage, Delivery System Reforms, Drugs, Devices, and Tests, Hospitals, Medicare Spending and Financing, Physicians And Other Health Professionals, Post-Acute Care, Private Plans, Quality

Mar 03, 2026 / Presentations

Medicare Part B premium payment basics

Research Areas:

Drugs, Devices, and Tests, Medicare Spending and Financing

Sep 11, 2025 / Comment Letters

MedPAC comment on CMS’s proposed rule on CY 2026 revisions to payment policies under the physician fee schedule and other changes to Part B payment policies

Research Areas:

Drugs, Devices, and Tests, Medicare Spending and Financing, Physicians And Other Health Professionals

Apr 12, 2024 / Presentations

Initial findings from analysis of Medicare Part B payment rates and 340B ceiling prices

Research Areas:

Drugs, Devices, and Tests, Medicare Spending and Financing